Company Registration No. 15072651 (England and Wales)
Seda Midco (UK) Limited
Annual report and financial statements
for the year ended 31 December 2025
Seda Midco (UK) Limited
Company information
Directors
C O T Barthelemy
P N Burrow
F G Casson
M D Frison
S G Kempsey
T S Patrick
Secretary
S C Harding
Company number
15072651
Registered office
6th Floor Belgrave House
76 Buckingham Palace Road
London
SW1W 9TQ
Auditor
Saffery LLP
71 Queen Victoria Street
London
EC4V 4BE
Seda Midco (UK) Limited
Contents
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Income statement
8
Statement of financial position
9
Statement of changes in equity
10
Statement of cash flows
11
Notes to the financial statements
12 - 18
Seda Midco (UK) Limited
Strategic report
For the year ended 31 December 2025
1
The Directors present their Strategic Report together with the audited financial statements of Seda Midco (UK) Limited ('the Company') for the period from 1 January 2025 to 31 December 2025.
Principal activities
The principal activity of the Company is to act as an investment holding company for the Skin Tech Pharma Group (“Skin Tech”, or “the Group”). The Company is ultimately controlled by funds advised by Charterhouse Capital Partners LLP ("Charterhouse"), a leading European private equity firm. The founders of Skin Tech hold minority stakes in the Group.
Review of the business
The Company holds an investment in Skin Tech. Skin Tech is a B2B medical aesthetics group specialising in the production of hyaluronic acid-based injectables, alongside topical peelings, mesotherapy and cosmetic products. The Group offers a large range of high-quality products manufactured in-house and sold under a suite of Skin Tech own brands, supported by a complementary contract manufacturing offering. Skin Tech’s products are currently sold in more than 80 countries globally. Its headquarters are located in Spain.
Principal risks and uncertainties
The principal risks are any impairments of the underlying investment held, and financial risks including cash and working capital management. The Company manages these risks through regular monitoring and review of net asset value of underlying investments, and actual cash flows against forecasts respectively.
Key performance indicators
The Company has net assets of €178,495k as at 31 December 2025 and a profit of €25,747k. Material investments held are at fair value, and hence the investment values given are considered to reflect the main activity of the Company.
Other information and explanations
Looking forward, the Company will continue to monitor the performance of its investment in Skin Tech and there are no significant developments or planned strategic changes to report. Skin Tech’s business has performed well and in line with expectations during the period.
Seda Midco (UK) Limited
Strategic report (continued)
For the year ended 31 December 2025
2
Section 172(1) Statement
Section 172 of the Companies Act 2006 requires directors to take into consideration the interests of stakeholders in their decision making. The Directors have regard to the interests of various stakeholders and the Company's reputation when making decisions. Such consideration is included in the statements set out below, noting the Directors' duty under s172 to act in good faith to promote the success of the Company for the benefit of its shareholders as a whole, but having regard amongst other matters to the following:
- the likely consequences of any decision in the long term;
- the interests of the Company's employees;
- the need to foster business relationships with suppliers, customers and others;
- the impact of the Company's operations on the community and environment;
- maintaining a reputation for high standards of business conduct; and
- the need to act fairly as between members of the Company.
As the Company is primarily a private limited holding company and has no employees, there are considered to be few stakeholders. During the period, the Company allotted 7,000,000 new Ordinary and Preference shares for a total subscription price of EUR 7,000,000. The Company itself did not see any significant developments, activities or transactions in respect of its own business during the period, apart from this increase.
The Directors are committed to high standards of business conduct and integrity at all times and take the interests of indirect stakeholders, such as the employees of Skin Tech, into consideration when making decisions that could affect the Group as a whole. Business relationships with the limited number of the Company’s own suppliers are maintained through regular dialogue.
Due to its limited activity, the overall impact of the Company on the environment and the community is considered low. Rigorous management of ESG matters takes place at the level of the operating entities within the Group, but progress is discussed and reviewed regularly by the Directors.
P N Burrow
Director
22 April 2026
Seda Midco (UK) Limited
Directors' report
For the year ended 31 December 2025
3
The Directors present their annual report and financial statements for the year ended 31 December 2025.
Results
The results for the year are set out on page 8.
Directors
The Directors who held office during the year and up to the date of signature of the financial statements were as follows:
C O T Barthelemy
P N Burrow
F G Casson
M D Frison
S G Kempsey
T S Patrick
Qualifying third party indemnity provisions
The Company has made qualifying third party indemnity provisions for the benefit of its Directors during the year. These provisions remain in force at the reporting date.
Auditor
The auditor, Saffery LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.
Energy and carbon report
As the Company has not consumed more than 40,000 kWh of energy in this reporting period, it qualifies as a low energy user under these regulations and is not required to report on its emissions, energy consumption or energy efficiency activities.
Statement of directors' responsibilities
The Directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
United Kingdom company law requires the Directors to prepare financial statements for each financial year. Under that law, the Directors have elected to prepare the financial statements in accordance with International Financial Reporting Standards (IFRSs) as adopted by the United Kingdom. Under company law, the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the Company for that period.
In preparing these financial statements, International Accounting Standard 1 requires that directors:
properly select and apply accounting policies;
present information, including accounting policies, in a manner that provides relevant, reliable, comparable and understandable information;
provide additional disclosures when compliance with the specific requirements in IFRSs are insufficient to enable users to understand the impact of particular transactions, other events and conditions on the entity's financial position and financial performance; and
make an assessment of the Company's ability to continue as a going concern.
The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company’s transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Seda Midco (UK) Limited
Directors' report (continued)
For the year ended 31 December 2025
4
Statement of disclosure to auditor
Each Director in office at the date of approval of this annual report confirms that:
so far as the Directors are aware, there is no relevant audit information of which the Company's auditor is unaware, and
the Directors have taken all the steps that they ought to have taken as a Director in order to make themselves aware of any relevant audit information and to establish that the Company's auditor is aware of that information.
This confirmation is given and should be interpreted in accordance with the provisions of section 418 of the Companies Act 2006.
Going Concern
At the time of approving the financial statements, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus the Directors continue to adopt the going concern basis of accounting in preparing the financial statements.
On behalf of the board
P N Burrow
Director
22 April 2026
Seda Midco (UK) Limited
Independent auditor's report
To the members of Seda Midco (UK) Limited
5
Opinion
We have audited the financial statements of Seda Midco (UK) Limited (the 'company') for the year ended 31 December 2025 which comprise the income statement, the statement of financial position, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and UK adopted international accounting standards.
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;
have been properly prepared in accordance with UK adopted international accounting standards; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
the information given in the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the directors' report has been prepared in accordance with applicable legal requirements.
Seda Midco (UK) Limited
Independent auditor's report
To the members of Seda Midco (UK) Limited (continued)
6
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud are detailed below.
Identifying and assessing risks related to irregularities:
We assessed the susceptibility of the company’s financial statements to material misstatement and how fraud might occur, including through discussions with the directors, discussions within our audit team planning meeting, updating our record of internal controls and ensuring these controls operated as intended. We evaluated possible incentives and opportunities for fraudulent manipulation of the financial statements. We identified laws and regulations that are of significance in the context of the company by discussions with directors and by updating our understanding of the sector in which the company operates.
Laws and regulations of direct significance in the context of the company include The Companies Act 2006 and UK Tax legislation.
Audit response to risks identified
We considered the extent of compliance with these laws and regulations as part of our audit procedures on the related financial statement items including a review of financial statement disclosures. We reviewed the company's records of breaches of laws and regulations, minutes of meetings and correspondence with relevant authorities to identify potential material misstatements arising. We discussed the company's policies and procedures for compliance with laws and regulations with members of management responsible for compliance.
Seda Midco (UK) Limited
Independent auditor's report
To the members of Seda Midco (UK) Limited (continued)
7
During the planning meeting with the audit team, the engagement partner drew attention to the key areas which might involve non-compliance with laws and regulations or fraud. We enquired of management whether they were aware of any instances of non-compliance with laws and regulations or knowledge of any actual, suspected or alleged fraud. We addressed the risk of fraud through management override of controls by testing the appropriateness of journal entries and identifying any significant transactions that were unusual or outside the normal course of business. We assessed whether judgements made in making accounting estimates gave rise to a possible indication of management bias. At the completion stage of the audit, the engagement partner’s review included ensuring that the team had approached their work with appropriate professional scepticism and thus the capacity to identify non-compliance with laws and regulations and fraud.
There are inherent limitations in the audit procedures described above and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.
A further description of our responsibilities is available on the Financial Reporting Council's website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Roger Weston (Senior Statutory Auditor)
For and on behalf of Saffery LLP
Statutory Auditors
71 Queen Victoria Street
London
EC4V 4BE
22 April 2026
Seda Midco (UK) Limited
Income statement
For the year ended 31 December 2025
8
2025
2024
Notes
€
€
Administrative expenses
(54,900)
(36,966)
Operating loss
(54,900)
(36,966)
Other gains and losses
5
25,802,291
41,418,823
Profit before taxation
25,747,391
41,381,857
Corporation tax expense
6
Profit and total comprehensive income for the year
25,747,391
41,381,857
Seda Midco (UK) Limited
Statement of financial position
As at 31 December 2025
9
2025
2024
Notes
€
€
Non-current assets
Investments
7
178,336,509
145,534,218
Current assets
Trade and other receivables
9
50,032
7,936
Cash and cash equivalents
147,889
249,064
197,921
257,000
Current liabilities
Trade and other payables
11
39,903
44,082
Net current assets
158,018
212,918
Net assets
178,494,527
145,747,136
Equity
Called up share capital
12
1,113,654
1,043,654
Share premium account
13
110,251,625
103,321,625
Retained earnings
67,129,248
41,381,857
Total equity
178,494,527
145,747,136
The notes on pages 12 to 18 form part of these financial statements.
The financial statements were approved by the board of directors and authorised for issue on 22 April 2026 and are signed on its behalf by:
P N Burrow
Director
Company registration number 15072651 (England and Wales)
Seda Midco (UK) Limited
Statement of changes in equity
For the year ended 31 December 2025
10
Share capital
Share premium account
Retained earnings
Total
Notes
€
€
€
€
Balance at 1 January 2024
1
1
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
41,381,857
41,381,857
Transactions with owners:
Issue of share capital
12
1,043,653
103,321,625
-
104,365,278
Balance at 31 December 2024
1,043,654
103,321,625
41,381,857
145,747,136
Year ended 31 December 2025:
Profit and total comprehensive income
-
-
25,747,391
25,747,391
Transactions with owners:
Issue of share capital
12
70,000
6,930,000
-
7,000,000
Balance at 31 December 2025
1,113,654
110,251,625
67,129,248
178,494,527
Seda Midco (UK) Limited
Statement of cash flows
For the year ended 31 December 2025
11
2025
2024
Notes
€
€
€
€
Cash flows from operating activities
Cash absorbed by operations
16
(101,175)
(4,419)
Net cash outflow from operating activities
(101,175)
(4,419)
Investing activities
Investment in subsidiaries
(7,000,000)
(104,115,395)
Proceeds from disposal of subsidiaries
-
3,600
Net cash used in investing activities
(7,000,000)
(104,111,795)
Financing activities
Proceeds from issue of shares
7,000,000
104,365,278
Net cash generated from financing activities
7,000,000
104,365,278
Net (decrease)/increase in cash and cash equivalents
(101,175)
249,064
Cash and cash equivalents at beginning of year
249,064
Cash and cash equivalents at end of year
147,889
249,064
Seda Midco (UK) Limited
Notes to the financial statements
For the year ended 31 December 2025
12
1
Accounting policies
Company information
Seda Midco (UK) Limited is a private company limited by shares incorporated in England and Wales. The registered office is 6th Floor Belgrave House, 76 Buckingham Palace Road, London, SW1W 9TQ.
1.1
Accounting convention
The financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted for use in the United Kingdom and with the requirements of the Companies Act 2006 applicable to companies reporting under IFRS, except as otherwise stated.
The financial statements are prepared in euros, which is the functional currency of the Company. Monetary amounts in these financial statements are rounded to the nearest €.
The financial statements have been prepared under the historical cost convention, except for the revaluation of Non-current Investments. The principal accounting policies adopted are set out below.
The Directors have determined that the Company is an investment entity as defined by IFRS10 Consolidated Financial Statements. Accordingly, the Company is exempt from the requirement to prepare consolidated financial statements.
1.2
Going concern
The trueDirectors have at the time of approving the financial statements, a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus the Directors continue to adopt the going concern basis of accounting in preparing the financial statements.
The Company is considered to be a going concern on the basis of its strong balance sheet, supported by the value of fixed asset investments, the performance of which are monitored on an ongoing basis by Directors with reference to future cash flows. Additionally, the Company has minimal operating financial obligations and the Directors are comfortable that cash levels are sufficient to meet these for the foreseeable future.
1.3
Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.4
Financial assets
Financial assets are recognised in the Company's statement of financial position when the Company becomes party to the contractual provisions of the instrument. Financial assets are classified into specified categories, depending on the nature and purpose of the financial assets.
At initial recognition, financial assets classified as fair value through profit and loss are measured at fair value and any transaction costs are recognised in profit or loss. Financial assets not classified as fair value through profit and loss are initially measured at fair value plus transaction costs.
Financial assets at fair value through profit or loss (FVPL)
When any of the above-mentioned conditions for classification of financial assets is not met, a financial asset is classified as measured at fair value through profit or loss. Financial assets measured at fair value through profit or loss are recognized initially at fair value and any transaction costs are recognised in profit or loss when incurred. A gain or loss on a financial asset measured at fair value through profit or loss is recognised in profit or loss, and is included within finance income or finance costs in the statement of income for the reporting period in which it arises.
Seda Midco (UK) Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
1
Accounting policies (continued)
13
Impairment of financial assets
Financial assets carried at FVPL are assessed for indicators of impairment at each reporting end date.
The expected credit losses associated with these assets are estimated on a forward-looking basis. A broad range of information is considered when assessing credit risk and measuring expected credit losses, including past events, current conditions, and reasonable and supportable forecasts that affect the expected collectability of the future cash flows of the instrument.
For trade receivables, the simplified approach permitted by IFRS 9 is applied, which requires expected lifetime losses to be recognised from initial recognition of the receivables.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership to another entity.
1.5
Financial liabilities
The Company recognises financial debt when the Company becomes a party to the contractual provisions of the instruments. Financial liabilities are classified as either 'financial liabilities at fair value through profit or loss' or 'other financial liabilities'.
Other financial liabilities
Other financial liabilities, including borrowings, trade payables and other short-term monetary liabilities, are initially measured at fair value net of transaction costs directly attributable to the issuance of the financial liability. They are subsequently measured at amortised cost using the effective interest method. For the purposes of each financial liability, interest expense includes initial transaction costs and any premium payable on redemption, as well as any interest or coupon payable while the liability is outstanding.
Derecognition of financial liabilities
Financial liabilities are derecognised when, and only when, the Company’s obligations are discharged, cancelled, or they expire.
1.6
Equity instruments
Equity instruments issued by the Company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.
Seda Midco (UK) Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
14
2
Critical accounting judgements and key sources of estimation uncertainty
In the application of the Company’s accounting policies, the Directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
Critical judgements
Fair value of investments
The Directors have made various assumptions concerning the current and future position when preparing the financial statements. The most significant judgements and estimates are included in note 7 in relation to the fair value of the investment.
3
Auditor's remuneration
2025
2024
Fees payable to the company's auditor and associates:
€
€
For audit services
Audit of the financial statements of the company
16,249
16,325
For other services
Tax services
5,416
5,441
4
Employees
The average monthly number of persons (including Directors) employed by the Company during the year was:
2025
2024
Number
Number
Total
0
0
5
Other gains and losses
2025
2024
€
€
Change in value of financial assets at fair value through profit or loss
25,802,291
41,418,823
Seda Midco (UK) Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
15
6
Tax (charge)/credit
The charge for the year can be reconciled to the profit per the income statement as follows:
2025
2024
€
€
Profit before taxation
25,747,391
41,381,857
Expected tax charge based on a corporation tax rate of 25.00% (2024: 25.00%)
6,436,848
10,345,464
Fair value gains not subject to taxation
(6,436,848)
(10,345,464)
Taxation charge for the year
-
-
7
Investments
Current
Non-current
2025
2024
2025
2024
€
€
€
€
Investments in subsidiaries
178,336,509
145,534,218
Investments in subsidiary companies are held at fair value. The Directors use an earnings multiple valuation methodology to determine the fair value. The most significant inputs in to the model are as follows:
Under IFRS 7 Financial Instruments: Disclosures and IFRS 13 Fair value measurement this is classified under the fair value hierarchy as Level 3.
The earnings multiple is based on publicly available information for comparable companies, the multiple is reviewed at least annually for accuracy and appropriateness. The Company is a holding company for an investment of funds managed by entities within the Charterhouse Capital Partners group, which routinely invests in and divests of businesses. As such, the Directors are able to assess the suitability of the methodology adopted and refine the methodology as circumstances change.
The most sensitive inputs to the model used are the earnings multiple used and the adjusted EBITDA due to the gearing effect of net debt.
Seda Midco (UK) Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
7
Investments (continued)
16
Movements in non-current investments
Shares in subsidiaries
€
Cost or valuation
At 1 January 2025
145,534,218
Valuation changes
25,802,291
Issue of new share capital
7,000,000
At 31 December 2025
178,336,509
Carrying amount
At 31 December 2025
178,336,509
At 31 December 2024
145,534,218
8
Subsidiaries
Details of the Company's subsidiaries at 31 December 2025 are as follows:
Name of undertaking
Registered office
Nature of business
Class of
shares held
% Held
Direct
Indirect
Seda Bidco (Spain), S.L.
calle Pla de l'Estany, 29
Castello D'Empuries
17486 Girona, Spain
Investment company
Ordinary and Preference
73.53
-
Skin Tech Pharma Group, S.L.U.
calle Pla de l'Estany, 29
Castello D'Empuries
17486 Girona, Spain
Cosmetic products
Ordinary
0
73.53
9
Trade and other receivables
2025
2024
€
€
Amount owed by parent undertaking
42,096
Amounts owed by subsidiary undertakings
7,936
7,936
50,032
7,936
10
Trade receivables - credit risk
Fair value of trade receivables
The Directors consider that the carrying amount of trade and other receivables is approximately equal to their fair value.
Seda Midco (UK) Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
10
Trade receivables - credit risk (continued)
17
No significant receivable balances are impaired at the reporting end date.
11
Trade and other payables
2025
2024
€
€
Amount owed to parent undertaking
116
Amounts owed to related parties
3,600
7,200
Accruals
36,303
36,766
39,903
44,082
12
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
€
€
Issued and fully paid
Ordinary of €0.01 each
1,113,654
1,043,654
11,137
10,437
2025
2024
2025
2024
Preference share capital
Number
Number
€
€
Issued and fully paid
Preference of €0.01 each
110,251,741
103,321,741
1,102,517
1,033,217
Preference shares classified as equity
1,102,517
1,033,217
Total equity share capital
1,113,654
1,043,654
The preference shares do not carry voting rights or dividend rights and are redeemable at the option of the Company. Each preference share is entitled to a proportionate share of surplus assets of the Company.
Reconciliation of movements during the year:
Ordinary
Preference
Number
Number
At 1 January 2025
1,043,654
103,321,741
Issue of fully paid shares
70,000
6,930,000
At 31 December 2025
1,113,654
110,251,741
On 24 March 2025, the Company allotted 70,000 Ordinary shares of €0.01 for €1.00 each and 6,930,000 preference shares of €0.01 for €1.00 each.
Seda Midco (UK) Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
18
13
Share premium account
2025
2024
€
€
At the beginning of the year
103,321,625
Issue of new shares
6,930,000
103,321,625
At the end of the year
110,251,625
103,321,625
14
Capital risk management
The Company is not subject to any externally imposed capital requirements.
15
Controlling party
The immediate parent of the Company is Seda Topco (UK) Limited, a private company limited by shares registered in England and Wales. The report and financial statements of Seda Topco (UK) Limited can be obtained from its registered office at 6th Floor Belgrave House, 76 Buckingham Palace Road, London, SW1W 9TQ.
The ultimate controlling party of the Company is Charterhouse GP LLP, an English limited liability partnership with registered office at 6th Floor, Belgrave House, 76 Buckingham Palace Road, London, SW1W 9TQ, acting in its capacity as manager of Charterhouse Capital Partners XI and of CCP Opportunities (I), each a collection of English limited partnerships. The report and financial statements of Charterhouse GP LLP can be obtained from its registered office.
16
Cash absorbed by operations
2025
2024
€
€
Profit for the year before taxation
25,747,391
41,381,857
Adjustments for:
Other gains and losses
(25,802,291)
(41,418,823)
Movements in working capital:
Increase in trade and other receivables
(42,096)
(7,935)
(Decrease)/increase in trade and other payables
(4,179)
40,482
Cash absorbed by operations
(101,175)
(4,419)
2025-12-312025-01-01falsefalseCCH SoftwareCCH Accounts Production 2025.300Mr C O T BarthelemyP N BurrowF G CassonM D FrisonS G KempseyT S PatrickS C Harding150726512025-01-012025-12-3115072651bus:Director22025-01-012025-12-3115072651bus:Director32025-01-012025-12-3115072651bus:Director42025-01-012025-12-3115072651bus:Director52025-01-012025-12-3115072651bus:Director62025-01-012025-12-3115072651bus:CompanySecretary12025-01-012025-12-3115072651bus:Director12025-01-012025-12-3115072651bus:RegisteredOffice2025-01-012025-12-31150726512025-12-3115072651core:ContinuingOperations2025-01-012025-12-31150726512024-01-012024-12-3115072651core:ContinuingOperations12025-01-012025-12-3115072651core:ContinuingOperations12024-01-012024-12-3115072651core:ContinuingOperations2024-01-012024-12-3115072651core:RetainedEarningsAccumulatedLosses2025-01-012025-12-3115072651core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3115072651core:Non-currentFinancialInstruments2025-12-3115072651core:Non-currentFinancialInstruments2024-12-31150726512024-12-31150726512024-12-31150726512023-12-3115072651core:ShareCapital2025-12-3115072651core:ShareCapital2024-12-3115072651core:SharePremium2025-12-3115072651core:SharePremium2024-12-3115072651core:RetainedEarningsAccumulatedLosses2025-12-3115072651core:RetainedEarningsAccumulatedLosses2024-12-3115072651core:SharePremium2023-12-3115072651core:OtherMiscellaneousReserve2023-12-3115072651core:ShareCapital2024-01-012024-12-3115072651core:SharePremium2024-01-012024-12-3115072651core:ShareCapital2025-01-012025-12-3115072651core:SharePremium2025-01-012025-12-311507265112025-01-012025-12-311507265112024-01-012024-12-3115072651core:CurrentFinancialInstruments2025-12-3115072651core:CurrentFinancialInstruments2024-12-3115072651core:Subsidiary12025-01-012025-12-3115072651core:Subsidiary22025-01-012025-12-3115072651core:Subsidiary112025-01-012025-12-3115072651core:Subsidiary222025-01-012025-12-3115072651bus:PrivateLimitedCompanyLtd2025-01-012025-12-3115072651bus:Audited2025-01-012025-12-3115072651bus:FullAccounts2025-01-012025-12-3115072651bus:FullIFRS2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP